NASDAQ:OGI Organigram Global (OGI) Stock Price, News & Analysis $1.73 +0.06 (+3.59%) Closing price 04:00 PM EasternExtended Trading$1.72 0.00 (-0.29%) As of 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Organigram Global Stock (NASDAQ:OGI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Organigram Global alerts:Sign Up Key Stats Today's Range$1.64▼$1.7650-Day Range$1.28▼$1.7352-Week Range$0.85▼$2.00Volume1.41 million shsAverage Volume1.02 million shsMarket Capitalization$231.91 millionP/E Ratio34.61Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada. Read More Organigram Global Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks9th Percentile Overall ScoreOGI MarketRank™: Organigram Global scored higher than 9% of companies evaluated by MarketBeat, and ranked 925th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Organigram Global. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Organigram Global are expected to grow in the coming year, from ($0.19) to ($0.06) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram Global is 34.61, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.18.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram Global is 34.61, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.56.Price to Book Value per Share RatioOrganigram Global has a P/B Ratio of 0.83. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.97% of the float of Organigram Global has been sold short.Short Interest Ratio / Days to CoverOrganigram Global has a short interest ratio ("days to cover") of 8.6.Change versus previous monthShort interest in Organigram Global has recently decreased by 3.75%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrganigram Global does not currently pay a dividend.Dividend GrowthOrganigram Global does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted5.97% of the float of Organigram Global has been sold short.Short Interest Ratio / Days to CoverOrganigram Global has a short interest ratio ("days to cover") of 8.6.Change versus previous monthShort interest in Organigram Global has recently decreased by 3.75%, indicating that investor sentiment is improving. News and Social Media2.2 / 5News SentimentN/A News SentimentOrganigram Global has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Organigram Global this week, compared to 2 articles on an average week.Search InterestOnly 3 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows4 people have added Organigram Global to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Organigram Global insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.09% of the stock of Organigram Global is held by insiders.Percentage Held by InstitutionsOnly 34.63% of the stock of Organigram Global is held by institutions.Read more about Organigram Global's insider trading history. Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram Global and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGI Stock News HeadlinesOrganigram Global (NASDAQ:OGI) vs. Akanda (NASDAQ:AKAN) Head to Head AnalysisAugust 21, 2025 | americanbankingnews.comOrganigram Global (NASDAQ:OGI) Lowered to Sell Rating by Wall Street ZenAugust 19, 2025 | americanbankingnews.comTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.August 28 at 2:00 AM | American Alternative (Ad)Atb Cap Markets Has Negative Outlook of OGI FY2025 EarningsAugust 19, 2025 | americanbankingnews.comFY2028 Earnings Estimate for OGI Issued By Atb Cap MarketsAugust 17, 2025 | americanbankingnews.comOGI FY2025 EPS Decreased by Alliance Global PartnersAugust 17, 2025 | americanbankingnews.comOrganigram Global Inc. (OGI) Q3 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comOrganigram reports Q3 revenue $70.8M, consensus $68.04MAugust 13, 2025 | msn.comSee More Headlines OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram Global's stock was trading at $1.61 on January 1st, 2025. Since then, OGI shares have increased by 7.5% and is now trading at $1.73. How were Organigram Global's earnings last quarter? Organigram Global Inc. (NASDAQ:OGI) issued its quarterly earnings results on Wednesday, August, 13th. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.02. The firm had revenue of $50.49 million for the quarter, compared to analysts' expectations of $68.04 million. Organigram Global had a net margin of 2.86% and a negative trailing twelve-month return on equity of 8.19%. Read the conference call transcript. When did Organigram Global's stock split? Shares of Organigram Global reverse split on the morning of Friday, July 7th 2023.The 1-4 reverse split was announced on Friday, July 7th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 7th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. Who are Organigram Global's major shareholders? Organigram Global's top institutional shareholders include Tidal Investments LLC (1.97%), AdvisorShares Investments LLC (0.60%), Baader Bank Aktiengesellschaft (0.19%) and Vontobel Holding Ltd. (0.05%). How do I buy shares of Organigram Global? Shares of OGI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Organigram Global own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram Global investors own include i3 Verticals (IIIV), Ford Motor (F), Lucid Group (LCID), Trade Desk (TTD), Finance of America Companies (FOA), NVIDIA (NVDA) and Company Calendar Last Earnings8/13/2025Today8/28/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:OGI CIK1620737 Webwww.organigram.ca Phone(844) 644-4726FaxN/AEmployees860Year FoundedN/AProfitability EPS (Trailing Twelve Months)$0.05 Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$33.39 million Net Margins2.86% Pretax Margin-1.50% Return on Equity-8.19% Return on Assets-5.79% Debt Debt-to-Equity RatioN/A Current Ratio2.59 Quick Ratio1.42 Sales & Book Value Annual Sales$117.47 million Price / Sales1.97 Cash FlowN/A Price / Cash FlowN/A Book Value$2.08 per share Price / Book0.83Miscellaneous Outstanding Shares134,050,000Free Float133,930,000Market Cap$231.91 million OptionableOptionable Beta1.45 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:OGI) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Global Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram Global With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.